
CASES Insights Into Current Approaches in HER2+ Breast Cancer
Perspectives on current treatment practices focusing on HER2+ breast cancer

Faculty Chair
Ian Krop, MD
Dana-Farber Cancer Institute, Boston, MA, USA
REPORT SNAPSHOT
Insights on the current approaches in HER2+ breast cancer were obtained from
- Current treatment practices regarding HER2+ metastatic breast cancer (mBC)
- Management of progressive HER2+ metastatic disease
- Current treatment practice attitudes toward recently introduced and upcoming agents
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated virtual roundtable discussion focusing on treatment of HER2+ breast cancer was held on November 2, 2020
- The group of advisors comprised 27 community oncologists from the southeast region of the US
- Data collection was accomplished through use of audience response system questioning both prior to and following the expert’s presentation and discussion with the faculty panel